Dimethyl Sulfoxide

The medical use of Dimethyl Sulfoxide is restricted by the FDA to the palliative treatment of interstitial cystitis and to certain experimental applications. It might be helpful in some forms of arthritis and connective tissue injuries. It might also be helpful in amyloidosis, in the prevention of skin ulceration induced by some antineoplastic agents, in reversing cerebral edema, in scleroderma, intracranial hypertension, and in the topical treatment of herpes zoster. It might have some anti-cancer, cardioprotective, and neuroprotective effects. It hasn't been established that it can halt degenerative joint disease progression.

Dimethyl Sulfoxide isn't a nutritional supplement or an over-the-counter product. The use of Dimethyl Sulfoxide for the treatment of interstitial cystitis requires a physician with expertise in this procedure. Bladder instillation might be harmful in individuals with urinary-tract malignancy. Individuals who receive long-term treatment with intravesical Dimethyl Sulfoxide should have liver and renal function tests and ophthalmologic evaluation performed every six months during treatment. Nursing mothers and women who are pregnant should avoid using Dimethyl Sulfoxide. Adverse reactions reported in individuals using Dimethyl Sulfoxide for treatment of interstitial cystitis include allergic reactions, anaphylactoid reactions, bladder spasm, discomfort, garlic-like taste, and transient chemical cystitis. Adverse reactions for topical use include burning eyes, garlic-like taste, headache, local dermatitis, nausea, sedation, and vomiting. Concurrent use of Dimethyl Sulfoxide and sulindac might cause peripheral neuropathy. Sulindac might lower the pharmacologic effects of Dimethyl Sulfoxide. Dimethyl Sulfoxide might impair sulindac's conversion to its sulfide metabolite. Peripheral neuropathy has been noted with the simultaneous use of Dimethyl Sulfoxide and sulindac. This website is intended to educate and inform, and should not replace discussions with your doctor.